Cargando…

P-glycoprotein Inhibition for Optimal Drug Delivery

P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distribution of xenobiotics and toxic substances. Hundreds of structurally diverse therapeutic agents are substrates to it and it impedes the absor...

Descripción completa

Detalles Bibliográficos
Autor principal:	Amin, Md. Lutful
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2013
Materias:	Short Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762612/ https://www.ncbi.nlm.nih.gov/pubmed/24023511 http://dx.doi.org/10.4137/DTI.S12519

Ejemplares similares

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023)

Intrinsically Fluorescent Anti-Cancer Drugs
por: Kabir, Md. Lutful, et al.
Publicado: (2022)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2014)

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
por: Dewanjee, Saikat, et al.
Publicado: (2017)

Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
por: Kim, Brandon J., et al.
Publicado: (2019)

P‐Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
por: Mealey, K.L., et al.
Publicado: (2015)

A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters
por: Razzaq, Sobia, et al.
Publicado: (2021)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
por: Kono, Yusuke, et al.
Publicado: (2021)

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms
por: Famta, Paras, et al.
Publicado: (2021)

P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016)

The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation
por: Senarathna, S M D K Ganga, et al.
Publicado: (2016)

Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant
por: Hanada, Kazuhiko
Publicado: (2017)

Carlina oxide inhibits the interaction of SARS-CoV-2 S glycoprotein with angiotensin-converting enzyme 2
por: Wnorowska, Sylwia, et al.
Publicado: (2022)

Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer
por: Tonissen, Kathryn F., et al.
Publicado: (2021)

Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein
por: Fujita, Yuria, et al.
Publicado: (2013)

Impact of molecular weight on the mechanism of cellular uptake of polyethylene glycols (PEGs) with particular reference to P-glycoprotein
por: Wang, Tingting, et al.
Publicado: (2020)

Regulation of P-Glycoprotein in the Brain
por: Chai, Amanda B., et al.
Publicado: (2022)

Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
por: Vankadari, Naveen
Publicado: (2020)

Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery
por: Mohebbi, Alireza, et al.
Publicado: (2021)

Inhibition of P-glycoprotein by two artemisinin derivatives
por: Steglich, Babette, et al.
Publicado: (2012)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
por: SOLEIMANIFARD, Simindokht, et al.
Publicado: (2014)

Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading for Transdermal Drug Delivery
por: Chandrashekar, N. S., et al.
Publicado: (2008)

3,3′,4,4′,5-Pentachlorobiphenyl Inhibits Drug Efflux Through P-Glycoprotein in KB-3 Cells Expressing Mutant Human P-Glycoprotein
por: Fujise, Hiroshi, et al.
Publicado: (2004)

Optimization of Nanoparticles for Smart Drug Delivery: A Review
por: Jia, Lina, et al.
Publicado: (2021)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
por: Karthika, Chenmala, et al.
Publicado: (2022)

Automatically Fixing Errors in Glycoprotein Structures with Rosetta
por: Frenz, Brandon, et al.
Publicado: (2019)

P-glycoprotein and chronic rhinosinusitis
por: Miyake, Marcel M., et al.
Publicado: (2018)

Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2
por: Ayyagari, Vijaya Sai
Publicado: (2022)

Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery
por: Juneja, Ridhima, et al.
Publicado: (2018)

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
por: Lai, Jiun-I, et al.
Publicado: (2020)

Selective modulation of P-glycoprotein-mediated drug resistance
por: Bebawy, M, et al.
Publicado: (2001)

Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein
por: Morishita, Hiroki, et al.
Publicado: (2020)

Formulation and characterisation of drug-loaded antibubbles for image-guided and ultrasound-triggered drug delivery
por: Kotopoulis, Spiros, et al.
Publicado: (2022)

Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum
por: Bhattacharyya, Suchita, et al.
Publicado: (2011)

Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine
por: Tessier, Nolwenn, et al.
Publicado: (2021)

Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy
por: Hoosain, Famida G., et al.
Publicado: (2015)

pH-Sensitive Mebeverine Microspheres for Colon Delivery
por: Dandagi, P. M., et al.
Publicado: (2009)

pH-Sensitive Biomaterials for Drug Delivery
por: Zhuo, Shijie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96ckb5f7dfem43gbkga7r82j4a